Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP.

Ranjbar, Hoda; Soti, Monavareh; Kohlmeier, Kristi A; Janahmadi, Mahyar; Shabani, Mohammad

Ranjbar, Hoda; Soti, Monavareh; Kohlmeier, Kristi A; Janahmadi, Mahyar; Shabani, Mohammad.

Afiliação

Ranjbar H; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
Soti M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran.
Kohlmeier KA; Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Janahmadi M; Department of Physiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shabani M; Neuroscience Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, 76198-13159, Iran. shabanimoh@yahoo.com.

BMC Neurosci ; 24(1): 18, 2023 03 03.

Article em En | MEDLINE | ID: mdl-36869289

Assuntos

Encéfalo; Células de Purkinje; Potenciais de Ação; Antagonistas de Receptores de Canabinoides; Técnicas de Patch-Clamp; Receptor CB1 de Canabinoide

Palavras-chave

Ataxia; CB1R; Cannabinoid; Cerebellum; Purkinje cell

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células de Purkinje / Encéfalo Idioma: En Revista: BMC Neurosci Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google